Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross A Abrams

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Current Problems in Cancer|October 26, 2002
Pancreatic cancerTheresa Pluth Yeo, Ralph H Hruban, Steven D Leach, et al.
Oncology (Williston Park, N.Y.)|July 17, 2016
ACR Appropriateness Criteria® Borderline and Unresectable Pancreas Cancer, William Small, John P Hayes, et al.
Annals of Surgery|January 11, 2011
A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activationEric Lutz, Charles J Yeo, Keith D Lillemoe, et al.
International Journal of Radiation Oncology, Biology, Physics|August 29, 2020
Impact of Diabetes and Insulin Use on Prognosis in Patients With Resected Pancreatic Cancer: An Ancillary Analysis of NRG Oncology RTOG 9704Danielle S Bitterman, Kathryn A Winter, Theodore S Hong, et al.
International Journal of Radiation Oncology, Biology, Physics|August 20, 2023
Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848Leila T Tchelebi, Kathryn A Winter, Ross A Abrams, et al.
American Journal of Clinical Oncology|January 28, 2020
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical TrialRoss A Abrams, Kathryn A Winter, Howard Safran, et al.
Journal of Neuro-Oncology|November 11, 2017
Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgeryMudit Chowdhary, Derick Okwan-Duodu, Jeffrey M Switchenko, et al.
Advances in Radiation Oncology|June 16, 2018
Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704William F Regine, Kathryn Winter, Ross A Abrams, et al.
The Oncologist|March 13, 2020
Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704Marsha Reyngold, Kathryn A Winter, William F Regine, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Current Problems in Cancer|October 26, 2002
Pancreatic cancerTheresa Pluth Yeo, Ralph H Hruban, Steven D Leach, et al.
Oncology (Williston Park, N.Y.)|July 17, 2016
ACR Appropriateness Criteria® Borderline and Unresectable Pancreas Cancer, William Small, John P Hayes, et al.
Annals of Surgery|January 11, 2011
A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activationEric Lutz, Charles J Yeo, Keith D Lillemoe, et al.
International Journal of Radiation Oncology, Biology, Physics|August 29, 2020
Impact of Diabetes and Insulin Use on Prognosis in Patients With Resected Pancreatic Cancer: An Ancillary Analysis of NRG Oncology RTOG 9704Danielle S Bitterman, Kathryn A Winter, Theodore S Hong, et al.
International Journal of Radiation Oncology, Biology, Physics|August 20, 2023
Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848Leila T Tchelebi, Kathryn A Winter, Ross A Abrams, et al.
American Journal of Clinical Oncology|January 28, 2020
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical TrialRoss A Abrams, Kathryn A Winter, Howard Safran, et al.
Journal of Neuro-Oncology|November 11, 2017
Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgeryMudit Chowdhary, Derick Okwan-Duodu, Jeffrey M Switchenko, et al.
Advances in Radiation Oncology|June 16, 2018
Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704William F Regine, Kathryn Winter, Ross A Abrams, et al.
The Oncologist|March 13, 2020
Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704Marsha Reyngold, Kathryn A Winter, William F Regine, et al.
Pageof 8